Search Within

Advanced Practice Providers

  1. "Cancer Research"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (1)
Groups
  1. Department of Medicine (11)
  2. Nursing (11)
  3. Solid Tumor Oncology Division (9)
  4. Breast Medicine Service (7)
  5. GSK Faculty (7)
  6. Surgery (7)

More Groups

People
  1. Jeanne Carter (3)
  2. Shari Goldfarb (3)
  3. Tari King (3)
  4. Ahmet Dogan (2)
  5. Alexander Drilon (2)
  6. Anna Park (2)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (1)
  6. 2016 (3)

More Years

Publications
  1. Cancer Research (14)
Publishers
  1. American Association for Cancer Research (14)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation
    Meeting Abstract

    Murciano-Goroff, Y. R.; Kannan, S.; Chang, J. C.; Benayed, R.; Blokhin, I.; Rekhtman, N.; Sisk, A. E.; Gibson, J.; Judka, L.; Kaplanis, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • OncoKB, MSK's precision oncology knowledge base
    Meeting Abstract

    Suehnholz, S. P.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; Ladanyi, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The optimal living and survivorship program: Piloting a novel cancer survivorship care model
    Meeting Abstract

    Corcoran, S.; Russell, J.; Clayton, J.; Smith, A.; Keenan, K.; Robson, M.; Iyengar, N.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Multispectral immunofluorescence identifies pS6 as a biomarker of intrinsic resistance to ruxolitinib in patients with relapsed/refractory T-cell lymphomas
    Meeting Abstract

    Ghione, P.; Moskowitz, A.; Kumar, P.; Knezevic, A.; Seshan, V.; Jacobsen, E.; Ruan, J.; Schatz, J.; Noor, S.; Myskowski, P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor
    Meeting Abstract

    Wang, J.; Yao, Z.; Jonsson, P.; Allen, A.; Qin, A. C. R.; Uddin, S.; Dunkel, I. J.; Petriccione, M.; Manova, K.; Haque, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Germline CDH1 mutations in lobular carcinoma in situ
    Meeting Abstract

    Reyes, S. A.; Sakr, R. A.; Schizas, M.; Towers, R.; Park, A. Y.; Ng, C. K. Y.; Weigelt, B.; Reis-Filho, J. S.; King, T. A.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Program evaluation of a female sexual medicine and women's health program
    Meeting Abstract

    Carter, J.; Seidel, B.; Stabile, C.; Baser, R.; Eaton, A.; Goldfarb, S.; Goldfrank, D.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Feasibility of a non-hormonal vaginal moisturizer in postmenopausal cancer survivors
    Meeting Abstract

    Carter, J.; Seidel, B.; Stabile, C.; Dickler, M.; Goldfrank, D.; Baser, R.; Goldfarb, S.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Epstein-Barr virus-specific cytotoxic T lymphocytes for treatment of rituximab-refractory Epstein-Barr virus-associated lymphoproliferative disorder
    Meeting Abstract

    Prockop, S. E.; Doubrovina, E.; Baroudy, K.; Boulad, F.; Khalaf, R.; Papadopoulos, E. B.; Sauter, C.; Szenes, V.; Suser, S.; Wasilewski, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save